Related Experiment Videos

Combined approach to functional constipation in children

S Amendola1, P De Angelis, L Dall'oglio

  • 1Digestive Surgery, Endoscopic Unit, Department of Gastroenterology, Bambino Gesù Children's Hospital, Rome, Italy.

Insights

A new medical-psychological treatment for functional constipation (FC) in children improved bowel regularity and reduced recurrence. This approach addresses behavioral patterns and family dynamics for sustained intestinal control.

Area of Science:

  • Pediatric Gastroenterology
  • Child Psychology
  • Family Therapy

Background:

  • Conventional treatments for functional constipation (FC) in children have a high recurrence rate.
  • International literature confirms the limitations of standard FC therapies.
  • A novel medical-psychological approach was developed to address these limitations.

Purpose of the Study:

  • To achieve sustained intestinal control in children with FC.
  • To prevent the recurrence of functional constipation through an innovative therapeutic strategy.
  • To evaluate the efficacy of a combined medical and psychological treatment for childhood FC.

Main Methods:

  • A study involving 25 children diagnosed with FC, assessing various associated symptoms and behavioral patterns.
  • Comprehensive questionnaires addressed eating, sleeping, school, toilet training, and daily routines of children and parents.
  • Treatment integrated increased fluid and fiber intake, laxatives, and family therapy focused on rules, autonomy, and paternal involvement.

Main Results:

  • FC onset averaged 3.5 years, often following stressful events, with 88% of cases linked to behavioral factors.
  • Post-therapy, 92% of children showed behavioral changes within one month, and 88% achieved regular bowel movements by three months.
  • Long-term follow-up (6-28 months) indicated that 68% sustained behavioral improvements and resolved pathological aspects of FC by one year.

Conclusions:

  • A multidisciplinary approach integrating medical and psychological interventions yields significant results for childhood functional constipation.
  • Establishing clear family rules and equalizing parental roles are key components for successful FC treatment.
  • This therapeutic model demonstrates consistent efficacy in managing and resolving functional constipation in pediatric patients.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.